Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. (Q35751042)
scientific article published on 19 December 2006
Language:
(P31) (Q13442814)
(P50) (Q89564940)
(Q66385504)
(Q90326364)
(Q16231524)
(Q91929755)
(Q114428067)
(Q114427914)
(P304) 3509-3512
(P407) (Q1860)
(P433) 8
(P478) 109
(P577) Tuesday, December 19, 2006
(P921) (Q32089)
(P1433) (Q885070)
(P1476) "Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML." (language: en)
(P2093) Karen W L Yee
C Ellen Jackson
Francis J Giles
(P2860) (Q28306356)
(Q27860757)
(Q29547767)
(Q36344439)
(Q24295120)
(Q29614242)
(Q35741937)
(Q35653049)
(Q24302566)
(Q40714220)
(Q40857867)
(Q44905183)
(Q43833445)
(Q80209074)
other details
description scientific article published on 19 December 2006

External Links